Literature DB >> 25024212

Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation.

Torsten Christ1, Nadiia Rozmaritsa2, Andreas Engel2, Emanuel Berk2, Michael Knaut3, Katharina Metzner2, Manuel Canteras4, Ursula Ravens2, Alberto Kaumann5.   

Abstract

Atrial fibrillation (AF) is the most common heart rhythm disorder. Transient postoperative AF can be elicited by high sympathetic nervous system activity. Catecholamines and serotonin cause arrhythmias in atrial trabeculae from patients with sinus rhythm (SR), but whether these arrhythmias occur in patients with chronic AF is unknown. We compared the incidence of arrhythmic contractions caused by norepinephrine, epinephrine, serotonin, and forskolin in atrial trabeculae from patients with SR and patients with AF. In the patients with AF, arrhythmias were markedly reduced for the agonists and abolished for forskolin, whereas maximum inotropic responses were markedly blunted only for serotonin. Serotonin and forskolin produced spontaneous diastolic Ca(2+) releases in atrial myocytes from the patients with SR that were abolished or reduced in myocytes from the patients with AF. For matching L-type Ca(2+)-current (ICa,L) responses, serotonin required and produced ∼ 100-fold less cAMP/PKA at the Ca(2+) channel domain compared with the catecholamines and forskolin. Norepinephrine-evoked ICa,L responses were decreased by inhibition of Ca(2+)/calmodulin-dependent kinase II (CaMKII) in myocytes from patients with SR, but not in those from patients with AF. Agonist-evoked phosphorylation by CaMKII at phospholamban (Thr-17), but not of ryanodine2 (Ser-2814), was reduced in trabeculae from patients with AF. The decreased CaMKII activity may contribute to the blunting of agonist-evoked arrhythmias in the atrial myocardium of patients with AF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25024212      PMCID: PMC4121801          DOI: 10.1073/pnas.1324132111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.

Authors:  D Dobrev; E Graf; E Wettwer; H M Himmel; O Hála; C Doerfel; T Christ; S Schüler; U Ravens
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

2.  Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort.

Authors:  Ulrich Schotten; Maura Greiser; Dirk Benke; Kai Buerkel; Britta Ehrenteidt; Christoph Stellbrink; Jaime F Vazquez-Jimenez; Friedrich Schoendube; Peter Hanrath; Maurits Allessie
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

3.  Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation.

Authors:  W J Manning; D I Silverman; S E Katz; M F Riley; P C Come; R M Doherty; J T Munson; P S Douglas
Journal:  J Am Coll Cardiol       Date:  1994-06       Impact factor: 24.094

4.  A 5-hydroxytryptamine receptor in human atrium.

Authors:  A J Kaumann; L Sanders; A M Brown; K J Murray; M J Brown
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases.

Authors:  T Christ; P Boknik; S Wöhrl; E Wettwer; E M Graf; R F Bosch; M Knaut; W Schmitz; U Ravens; D Dobrev
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

6.  Competitive cAMP antagonists for cAMP-receptor proteins.

Authors:  P J Van Haastert; R Van Driel; B Jastorff; J Baraniak; W J Stec; R J De Wit
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

7.  Beta-adrenergic stimulation of pig myocytes with decreased cytosolic free magnesium prolongs the action potential and enhances triggered activity.

Authors:  Shao-Kui Wei; Stephen U Hanlon; Mark C P Haigney
Journal:  J Cardiovasc Electrophysiol       Date:  2002-06

8.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

9.  Both beta 1- and beta 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium.

Authors:  A J Kaumann; L Sanders
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

10.  Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.

Authors:  K B Seamon; W Padgett; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  32 in total

Review 1.  Atrial remodeling, fibrosis, and atrial fibrillation.

Authors:  José Jalife; Kuljeet Kaur
Journal:  Trends Cardiovasc Med       Date:  2014-12-31       Impact factor: 6.677

Review 2.  Research progress on the role of CaMKII in heart disease.

Authors:  Shi-Jun Jiang; Wei Wang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

3.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

Review 4.  Calcium-mediated cellular triggered activity in atrial fibrillation.

Authors:  Dobromir Dobrev; Xander H T Wehrens
Journal:  J Physiol       Date:  2017-03-22       Impact factor: 5.182

5.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 6.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

7.  Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation.

Authors:  Katherina M Alsina; Mohit Hulsurkar; Sören Brandenburg; Daniel Kownatzki-Danger; Christof Lenz; Henning Urlaub; Issam Abu-Taha; Markus Kamler; David Y Chiang; Satadru K Lahiri; Julia O Reynolds; Ann P Quick; Larry Scott; Tarah A Word; Maria D Gelves; Albert J R Heck; Na Li; Dobromir Dobrev; Stephan E Lehnart; Xander H T Wehrens
Journal:  Circulation       Date:  2019-06-12       Impact factor: 29.690

Review 8.  Calcium signalling silencing in atrial fibrillation.

Authors:  Maura Greiser
Journal:  J Physiol       Date:  2017-05-14       Impact factor: 5.182

9.  In permanent atrial fibrillation, PDE3 reduces force responses to 5-HT, but PDE3 and PDE4 do not cause the blunting of atrial arrhythmias.

Authors:  Emanuel Berk; Torsten Christ; Simon Schwarz; Ursula Ravens; Michael Knaut; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

Review 10.  Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.

Authors:  Andrea Rague; Kevin Tidgewell
Journal:  Mini Rev Med Chem       Date:  2018       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.